Biocon Biologics Clears U.S. Path for Interchangeable Aflibercept Biosimilar Yesafili Through Regeneron Settlement

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd announced  a settlement and license agreement...

April 16, 2025 | Wednesday | News
Atelerix Partners with MineBio to Launch Cryo-Free Cell Preservation Technology in China

Partnership with specialist life science distributor establishes sales channel in high-demand market and strengthens global network Hypothermic pres...

April 16, 2025 | Wednesday | News
Lecanemab Becomes First Approved Disease-Modifying Therapy for Early Alzheimer’s in the EU

In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild de...

April 16, 2025 | Wednesday | News
Precision Medicine in Asia: From Genomics to Oncology Impact

    As Asia accounts for nearly half of the world’s cancer burden, the push toward precision medicine is more critical than ever. In this...

April 11, 2025 | Friday | Interview
Shilpa Pharma Lifesciences Passes Second Consecutive FDA Inspection with No Observations

Shilpa Medicare announces that Shilpa Pharma Lifesciences – a wholly owned subsidiary – has successfully passed a U.S. Food and Drug Admin...

April 10, 2025 | Thursday | News
China’s Telitacicept Sets New Benchmark in gMG Treatment with Landmark Phase 3 Results

Impressive results of the Phase 3 clinical trial (NCT05737160) evaluating the efficacy and safety of Telitacicept (synonym: RC18; brand name: 泰爱®...

April 09, 2025 | Wednesday | News
Singapore’s NUS Integrates AI and 3D Bioprinting to Transform Personalised Gum Tissue Grafts

Artificial intelligence streamlines the optimisation of bioprinting parameters for oral soft tissue grafts, reducing time and resourc...

April 04, 2025 | Friday | Reports
India’s Gennova Biopharmaceuticals Partners with CEPI to Advance AI-Enhanced Self-Amplifying mRNA Vaccines

Gennova Biopharmaceuticals Ltd., a pioneering company in mRNA technology and vaccine development, is proud to announce a strategic partnership with the C...

April 01, 2025 | Tuesday | News
Akeso Advances Global Leadership in Bispecific Antibodies with Approvals for Ivonescimab and Cadonilimab

Akeso Inc. (9926.HK), a leading biopharmaceutical company, has announced major advancements in its antibody drug pipeline, underscoring a transformative ...

March 31, 2025 | Monday | News
China Grants Breakthrough Therapy Designation to Innovent’s IBI363 for Hard-to-Treat Melanoma

Innovent Biologics, Inc.  a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the trea...

March 31, 2025 | Monday | News
SK pharmteco Embarks on My Green Lab Certification to Advance Sustainable Laboratory Practices

-SK pharmteco, a global pharmaceutical subcontract development and manufacturing organization, CDMO), has just reached an important step in its sustainab...

March 14, 2025 | Friday | News
Belén Garijo Leads Merck Back to Profitable Growth, Delivering Strong 2024 Performance

  Key Financial Highlights: Full-year net sales increased to €21.2 billion (organically: +2.0%) EBITDA pre rose to €6.1 billion (orga...

March 06, 2025 | Thursday | Company results
Enzene India Secures EU GMP Certification for Pune Facilities, Strengthening Global Biologics Manufacturing

Enzene, a pioneer in fully-connected continuous biologics manufacturing technology, today announced that its two facilities in Pune have received Europea...

March 05, 2025 | Wednesday | News
Callio Therapeutics Launches with $187M Series A for ADC Cancer Therapy

Callio Therapeutics, a biotechnology company focused on realizing the promise of multi-payload antibody-drug conjugates (ADCs) to improve cancer therapy, a...

March 04, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close